2024 HCPCS Code C9073
Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
TAGS: viable brexucabtagene positive preparation leukapheresis autologous therapeutic million
Notice | HCPCS C9073 terminated on March 31, 2021. |
Short Description | Brexucabtagene autoleucel ca |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | April 01, 2021 |
HCPCS Code Added Date | January 01, 2021 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 9 - Other medical items or services |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- C2614 - Probe, perc lumb disc
- C2615 - Sealant, pulmonary, liquid
- C2616 - Brachytx, non-str,yttrium-90
- C2617 - Stent, non-cor, tem w/o del
- C2618 - Probe/needle, cryo
- C2619 - Pmkr, dual, non rate-resp
- C2620 - Pmkr, single, non rate-resp
- C2621 - Pmkr, other than sing/dual
- C2622 - Prosthesis, penile, non-inf
- C2623 - Cath, translumin, drug-coat
- C2624 - Wireless pressure sensor
- C2625 - Stent, non-cor, tem w/del sy
- C2626 - Infusion pump, non-prog,temp
- C2627 - Cath, suprapubic/cystoscopic
- C2628 - Catheter, occlusion
- C2629 - Intro/sheath, laser
- C2630 - Cath, ep, cool-tip
- C2631 - Rep dev, urinary, w/o sling
- C2634 - Brachytx, non-str, ha, i-125
- C2635 - Brachytx, non-str, ha, p-103